Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 3, 2006, Pages 529-535

  Struijk, Linda ^a   Hall, Lisa ^b   Van Der Meijden, Els ^a   Wanningen, Patrick ^a   Bavinck, Jan Nico Bouwes ^a   Neale, Rachel ^b   Green, Adèle C ^b   Ter Schegget, Jan ^a   Feltkamp, Mariet C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYEBROW; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 20; HUMAN PAPILLOMAVIRUS TYPE 24; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 8; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGE DISTRIBUTION; AGED; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DNA PROBES, HPV; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INCIDENCE; KERATOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SKIN NEOPLASMS;

EID: 33645498093     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0747     Document Type: Article

References (33)

1. Marks R. Squamous cell carcinoma. Lancet 1996;347:735-8.
2. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88:10124-8.
3. de Villiers E-M, Fauquet C, Broker TR, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.
4. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000;61:289-97.
5. Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003;295:273-9.
6. Harwood CA, Spink PJ, Surentheran T, et al. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers. J Invest Dermatol 1998;111:123-7.
7. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002;15:101-14.
8. Berkhout RJ, Tieben LM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
9. Berkhout RJ, Bouwes Bavinck JN, Ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000;38:2087-96.
10. Boxman IL, Russell A, Mulder LH, Bouwes Bavinck JN, Ter Schegget J, Green A. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol 2001;117:1108-12.
11. Boxman IL, Russell A, Mulder LH, Bouwes Bavinck JN, Ter Schegget J, Green A. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group. Int J Cancer 2000;86:118-21.
12. de Villiers EM, Lavergne D, McLaren K, Benton EC. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997;73:356-61.
13. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996;88:802-11.
14. De Jong-Tieben LM, Berkhout RJ, Ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000;69:44-9.
15. De Jong-Tieben LM, Berkhout RJ, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995;105:367-71.
16. Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 2000;19:592-8.
17. Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000;14:3065-73.
18. Caldeira S, Zehbe I, Accardi R, et al. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol 2003;77:2195-206.
19. Struijk L, Bouwes Bavinck JN, Wanningen P, et al. Presence of Human Papillomavirus DNA in PLucked Eyebrow Hairs Is Associated with a History of Cutaneous Squamous Cell Carcinoma. J Invest Dermatol 2003;121:1531-5.
20. Feltkamp MC, Broer R, di Summa FM, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003;63:2695-700.
21. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001;253:153-62.
22. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
23. Astori G, Lavergne D, Benton C, et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998;110:752-5.
24. Boxman IL, Berkhout RJ, Mulder LH, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997;108:712-5.
25. Green A, Battistutta D, Hart V, et al. Skin cancer in a subtropical Australian population: Incidence and lack of association with occupation. Am J Epidemiol 1996;144:1034-40.
26. Meschede W, Zumbach K, Braspenning J, et al. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol 1998;36:475-80.
27. Tjiong MY, Zumbach K, Ter Schegget J, et al. Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia. Viral Immunol 2001;14:415-24.
28. Tjiong MY, Ter Schegget J, Tjong AH, et al. IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia. Int J Gynecol Cancer 2000;10:296-304.
29. Stark S, Petridis AK, Ghim SJ, et al. Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 1998;111:696-701.
30. Masini C, Fuchs PG, Gabrielli F, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003;139:890-4.
31. Weissenborn SJ, Nindl I, Purdie K, et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005;125:93-7.
32. Giampieri S, Storey A. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomavirus types 5 and 18. Br J Cancer 2004;90:2203-9.
33. Iftner T, Elbel M, Schopp B, et al. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 2002;21:4741-8.